These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19174703)

  • 1. Effects of diet and gemfibrozil on posttransplant hyperlipidemia in renal transplant recipients.
    Sapan M; Ozben B; Yakupoglu G; Suleymanlar G; Ozben T
    J Investig Med; 2009 Feb; 57(2):456-9. PubMed ID: 19174703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of fenofibrate or gemfibrozil on serum lipid profiles in Chinese patients with type IIb hyperlipidemia: a single-blind, randomized, and cross-over study.
    Jen SL; Chen JW; Lee WL; Wang SP
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Apr; 59(4):217-24. PubMed ID: 9216117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperlipidemia after renal transplantation: treatment with gemfibrozil.
    Chan TM; Cheng IK; Tam SC
    Nephron; 1994; 67(3):317-21. PubMed ID: 7936022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of lipid-lowering agents on acute renal allograft rejection.
    Kasiske BL; Heim-Duthoy KL; Singer GG; Watschinger B; Germain MJ; Bastani B
    Transplantation; 2001 Jul; 72(2):223-7. PubMed ID: 11477342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effects of Xuezhikang on serum lipid profile, thromboxane A2 and prostacyclin in patients with hyperlipidemia].
    Jian J; Hao X; Deng C; Zhou H; Lin J
    Zhonghua Nei Ke Za Zhi; 1999 Aug; 38(8):517-9. PubMed ID: 11798687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hyperlipidemia in renal transplant patients with gemfibrozil and dietary modification.
    Knight RJ; Vathsala A; Schoenberg L; Camel S; Weinberg RB; Goldstein RA; Lewis RM; van Buren CT; Kahan BD
    Transplantation; 1992 Jan; 53(1):224-5. PubMed ID: 1733073
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of vitamin E and gemfibrozil on lipid profiles, lipid peroxidation and antioxidant status in the elderly and young hyperlipidemic subjects.
    Sutken E; Inal M; Ozdemir F
    Saudi Med J; 2006 Apr; 27(4):453-9. PubMed ID: 16598319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of fluvastatin on hyperlipidemia after renal transplantation.
    Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H
    Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gemfibrozil in the treatment of hyperlipidemia].
    Wang JJ; Song YM; Wang YS; Lin WH
    Zhonghua Yi Xue Za Zhi (Taipei); 1989 Feb; 43(2):131-4. PubMed ID: 2766068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of gemfibrozil and orlistat for treatment of combined hyperlipidemia with predominant hypertriglyceridemia.
    Tolentino MC; Ferenczi A; Ronen L; Poretsky L
    Endocr Pract; 2002; 8(3):208-12. PubMed ID: 12113634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
    Pflugfelder PW; Huff M; Oskalns R; Rudas L; Kostuk WJ
    J Heart Lung Transplant; 1995; 14(4):613-22. PubMed ID: 7578166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of gemfibrozil on hyperlipidemia in children with persistent nephrotic syndrome.
    Büyükçelik M; Anarat A; Bayazit AK; Noyan A; Ozel A; Anarat R; Aydingülü H; Dikmen N
    Turk J Pediatr; 2002; 44(1):40-4. PubMed ID: 11858378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
    Akçiçek F; Ok E; Duman S; Kürsad S; Unsal A; Alev M; Atabay G; Basçi A
    Adv Perit Dial; 1996; 12():261-5. PubMed ID: 8865916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approaches to the treatment of hyperlipidemia in the solid organ transplant recipient.
    Kirk JK; Dupuis RE
    Ann Pharmacother; 1995 Sep; 29(9):879-91. PubMed ID: 8547738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of gemfibrozil on change in renal function in men with moderate chronic renal insufficiency and coronary disease.
    Tonelli M; Collins D; Robins S; Bloomfield H; Curhan GC
    Am J Kidney Dis; 2004 Nov; 44(5):832-9. PubMed ID: 15492949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term Treatment With Pravastatin Alone and in Combination With Gemfibrozil in Familial Type IIB Hyperlipoproteinemia or Combined Hyperlipidemia.
    Napoli C; Lepore S; Chiariello P; Condorelli M; Chiariello M
    J Cardiovasc Pharmacol Ther; 1997 Jan; 2(1):17-26. PubMed ID: 10684438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-transplant hyperlipidemia: risk factors and response to dietary modification and gemfibrozil therapy.
    Bastani B; Robinson S; Heisler T; Puntney G; Aridge D; Lindsey L; Solomon H; Garvin PJ
    Clin Transplant; 1995 Aug; 9(4):340-8. PubMed ID: 7579744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between duration dependent effects of Simvastatin and Gemfibrozil on dyslipidemia in patients with type 2 diabetes.
    Ashraf R; Amir K; Shaikh AR
    J Pak Med Assoc; 2005 Aug; 55(8):324-7. PubMed ID: 16164158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prudent algorithm for hyperlipoproteinemia in renal transplant recipients.
    Nart A; Uslu A; Bozkaya G; Aykas A; Dogan M; Karaca B
    Transplant Proc; 2009 Mar; 41(2):751-5. PubMed ID: 19328972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin down regulates mRNA expression of RANTES and CCR5 in posttransplant renal recipients with hyperlipidemia.
    Li Q; Wang D; Wang Y; Xu Q
    Transplant Proc; 2006 Nov; 38(9):2899-904. PubMed ID: 17112859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.